Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zuyderland operates as one of the largest teaching hospitals and integrated healthcare providers in the Limburg region of the Netherlands. It specializes in oncology, obesity, neurocognitive disorders, mobility issues, and interstitial lung disease. The organization was formed from the merger of Atrium Medical Center Parkstad and Orbis Medical and Care Concern Sittard-Geleen in January 2015. It offers acute hospital care, long-term care including nursing homes and hospices, home care services, youth health programs, rehabilitation services, and domestic help. As a top clinical training center affiliated with Maastricht UMC+, it also plays an important role in medical education and innovation. The organization participates in clinical trials—often phase II–IV—in partnership with academic centers such as Maastricht University Medical Center+. However, it does not develop its own drugs or therapeutic platforms. Recent investments have focused on modernizing facilities for both acute medicine and long-term/chronic disease management to meet regional needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zuyderland.